Diversify Advisory Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Buy
+70,713
New +$2.36M 0.04% 378
2025
Q2
– Sell
-10,294
Closed -$160K – 867
2025
Q1
$160K Sell
10,294
-10,061
-49% -$180K 0.01% 621
2024
Q4
$426K Buy
20,355
+496
+2% +$9.02K 0.02% 397
2024
Q3
$365K Buy
19,859
+9,693
+95% +$170K 0.02% 452
2024
Q2
$161K Sell
10,166
-4
-0% -$62 0.01% 612
2024
Q1
$141K Buy
+10,170
New +$128K 0.01% 619

Other funds holding TEVA

Diversify Advisory Services's TEVA Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 70,713 shares worth $2.2M. The stake represents 0.04% of the portfolio and ranks #378 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in TEVA as recently as Q1 2025.

Diversify Advisory Services first reported a position in TEVA in Q1 2024 and has held it in 6 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Diversify Advisory Services held 70,713 shares of Teva Pharmaceutical Industries Limited worth $2.2M as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Diversify Advisory Services position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.04% of Diversify Advisory Services's portfolio in Q2 2026, its #378 holding.
  • Diversify Advisory Services first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and has held it in 6 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.